[PHP115] Preliminary Analysis of the Unwritten Decision Rules Behind the French Transparency Commission’S Assessment of Drugs
2011 Value in health
Toumi, M. | Michel, M. | Mraidi, M. | Rahmouni, A. | Duvillard, R. |
Volume: 14,
Issue: 7,
Pages: A354,
a,
Our objective was to analyze the French HTA decision making process of the Transparency Commission (TC) and try to identify unwritten decision rules which influence a drug’s SMR and ASMR.
